TriNav Clinical Evidence Flashcards

1
Q

Compared to Traditional Microcatheter, PEDD Achieved what % Increase in ORR? (Response)

A

23% Increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Compared to Traditional Microcatheter, PEDD Achieved what % Increase in More on target distribution? (Accuracy)

A

34% More on Target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Compared to Traditional Microcatheter, PEDD Achieved what mean %? (Saftey)

A

Mean 58%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Compared to Traditional Microcatheter, PEDD Achieved what % Increase in pathological response? (Response)

A

55% Increased Pathological Response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Compared to Traditional Microcatheter, PEDD Achieved what % Increase in tumor dose? (Response)

A

23% Increase in tumor dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

d’Abadie Study
Compared to Traditional Microcatheter, PEDD Achieved what % Increase to T:N (Accuracy)

A

24% Increase in T:N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Who authored the clinical summary showing a 23% increase in ORR (Response)

A

Titano, JJ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Who authored the clinical summary showing a 34% more on target distribution? (Accuracy)

A

Titano, JJ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Who authored the clinical summary showing a mean of 58% decrease in non-target embolization? (Protection)

A

Pasciak, AS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Who authored the clinical summary showing a 23% Increase in tumor dose? (Response)

A

d’Abadie, P.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Who authored this paper showing these results?

Penetration
Improved particle penetration with PEDD using same sized particles in similar sized vessels

Safety
Helps protect against non-target delivery.
100% vs 72%
Embolization efficiency, PEDD vs. Traditional Microcatheter (p<0.05)

A

Arepally, A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Who authored this paper showing these results?

Penetration
68% (range: 33% - 90%)
Increase in tumor deposition, PEDD vs. Traditional Microcatheter (p<0.05)

Accuracy
100%
Improved T:N ratio in all study patients

Safety
Mean 58% (range: 24% - 89%)
Decrease in non-target embolization, PEDD vs. Traditional Microcatheter (p<0.05)

A

Pasciak, AS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Who authored this paper showing these results?

Penetration
23%
Increase in tumor dose, PEDD vs. Traditional Microcatheter (p<0.001)

Accuracy
24%
Increase in T:N, PEDD vs. Traditional Microcatheter (p<0.001)

A

d’Abadie, P.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Who authored this paper showing these results?

Imaging Response
100% vs 77%
23% Increase ORR/Imaging
PEDD vs. Traditional Microcatheter (p=0.019)

Pathologic Response
89% vs 34%
55% Increased Pathological Response
PEDD vs. Traditional Microcatheter (p=0.026)

Accuracy
89% vs 55%
34% More on-target
Particles in tumor, PEDD vs. Traditional Microcatheter (p=0.002)

A

Titano, JJ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The existing body of PEDD data demonstrating improvement vs. traditional microcatheters has been validated, expanded and enhanced by

A

Real World Evidence (RWE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What data has shown that, TriNav is used to treat complex patients and achieves the same or better results than when less sick patients are treated with EH

A

Real World Evidence (RWE)

15
Q

(RWE) Matched cohort analyses of TARE patients with HCC and with CRC liver metastases revealed what?

A. TriNav HCC patients received more liver transplants than non-TriNav patients post-procedure
B. TriNav patients had fewer 30-day inpatient visits than non-TriNav patients post-procedure
C. TriNav CRCLM patients had fewer overall clinical complications than non-TriNav patients post-procedure
D. All of the above

A

D. All of the Above